Key Points
-
Coeliac disease is a T cell-mediated enteropathy that has an autoimmune component and is induced by dietary wheat gluten. The ability to access to the targeted tissue during active (from patients on a gluten-containing diet) and non-active (from patients on a gluten-free diet) disease conditions makes it a unique human model to obtain insights into autoimmune disorders.
-
Coeliac disease is a multigenic complex immune disorder. The main genetic factors associated with coeliac disease are the MHC class II genes that encode HLA-DQ2 and HLA-DQ8. They contribute to at least 30% of the genetic heritability of the disease; the non-HLA genes identified to date contribute to only 3–4%.
-
The tissue enzyme transglutaminase 2 requires inflammatory signals to become activated in the tissue environment. Once it is activated, it deamidates gluten peptides, introducing negative charges that increase the binding affinity of the gluten peptides for HLA-DQ2 and HLA-DQ8.
-
Resistance to proteolytic cleavage and post-translational modifications of gluten, combined with particular physicochemical properties of HLA-DQ2 and HLA-DQ8 molecules, provide the basis for the association of coeliac disease with HLA-DQ2 or HLA-DQ8.
-
The presence of inflammatory mediators in the tissue environment may explain why intestinal dendritic cells induce an inflammatory response instead of a regulatory gluten-specific immune response; their presence may also explain why effector T cells become resistant to the inhibitory effects of regulatory T cells.
-
Intraepithelial cytotoxic lymphocytes require signals from target tissue cells to become licensed killer cells and to mediate tissue damage. In particular, interleukin-15 and non-classical MHC molecules expressed by intestinal epithelial cells reduce the activation threshold and promote the lytic activity of cytotoxic T cells by upregulating and activating natural killer cell receptors.
Abstract
Coeliac disease is an inflammatory disorder with autoimmune features that is characterized by destruction of the intestinal epithelium and remodelling of the intestinal mucosa following the ingestion of dietary gluten. A common feature of coeliac disease and many organ-specific autoimmune diseases is a central role for T cells in causing tissue destruction. In this Review, we discuss the emerging hypothesis that, in coeliac disease, intestinal tissue inflammation — induced either by infectious agents or by gluten — is crucial for activating T cells and eliciting their tissue-destructive effector functions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Green, P. H. & Cellier, C. Celiac disease. N. Engl. J. Med. 357, 1731–1743 (2007).
Janeway, C. A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11–16 (1992).
Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nature Immunol. 8, 11–13 (2007).
Kalinski, P., Hilkens, C. M., Wierenga, E. A. & Kapsenberg, M. L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20, 561–567 (1999).
Mora, J. R. et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88–93 (2003).
Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757–1764 (2007).
Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256–260 (2007).
Meresse, B. & Jabri, B. NKG2 Receptor-Mediated Regulation Of Effector CTL Functions In The Human Tissue Microenvironment (eds Vivier, E. & Colonna, M.) (Springer, 2006).
Ruprecht, C. R. et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. 201, 1793–1803 (2005).
Benahmed, M. et al. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182, 6763–6770 (2009).
Sollid, L. M. et al. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J. Exp. Med. 169, 345–350 (1989).
Spurkland, A., Sollid, L. M., Polanco, I., Vartdal, F. & Thorsby, E. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum. Immunol. 35, 188–192 (1992).
Nistico, L. et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55, 803–808 (2006).
van Heel, D. A. et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nature Genet. 39, 827–829 (2007). The first genome wide association study of coeliac disease.
Hunt, K. A. et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nature Genet. 40, 395–402 (2008).
Leonard, W. J. & Spolski, R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nature Rev. Immunol. 5, 688–698 (2005).
Salvati, V. M. et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 50, 186–190 (2002).
Nilsen, E. M. et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115, 551–563 (1998).
Smyth, D. J. et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359, 2767–2777 (2008).
Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561–574 (2004).
Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genet. 27, 18–20 (2001).
Shan, L. et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2275–2279 (2002). This paper establishes a relationship between the inability of intestinal proteases to break down gluten and the generation of an immunodominant gluten peptide for HLA-DQ2-positive patients. It also introduces bacterial prolyl endopeptidase as a potential supplement therapy in coeliac disease.
Arentz-Hansen, H. et al. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191, 603–612 (2000).
Moustakas, A. K. et al. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int. Immunol. 12, 1157–1166 (2000).
Molberg, Ø. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med. 4, 713–717 (1998); erratum 4, 974 (1998). The first paper to show that TG2 can post-translationally modify gluten peptides by deamidation and that T cells of the coeliac lesion preferentially recognize deamidated gluten peptides.
van de Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161, 1585–1588 (1998).
Mazzarella, G. et al. Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterology 134, 1017–1027 (2008).
Troncone, R. et al. In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA. Gastroenterology 111, 318–324 (1996).
Maiuri, L. et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362, 30–37 (2003). This paper reports the ability of the 31–43 α-gliadin peptide, which is not recognized by T cells, to mediate innate immune effects in the coeliac mucosa.
Hüe, S. et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367–377 (2004). The first paper to show that gluten can induce expression of MICs by IECs.
Barone, M. V. et al. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 56, 480–488 (2007).
Terrazzano, G. et al. Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J. Immunol. 179, 372–381 (2007).
Cinova, J. et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J. Clin. Immunol. 27, 201–209 (2007).
Nikulina, M., Habich, C., Flohe, S. B., Scott, F. W. & Kolb, H. Wheat gluten causes dendritic cell maturation and chemokine secretion. J. Immunol. 173, 1925–1933 (2004).
Junker, Y., Leffler, D. A., Wieser, H. & Schuppan, D. Gliadin activates monocytes, macrophages and dendritic cells in vitro and in vivo via Toll like receptor 4. Gastroenterology 136, A468 (2009).
Lammers, K. M. et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135, 194–204. e3 (2008).
Doyle, H. A. & Mamula, M. J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22, 443–449 (2001).
Siegel, M. et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS ONE 3, e1861 (2008). This paper shows for the first time that TG2 is not constitutively active in the intestine and can be activated on TLR3-induced tissue injury.
Hovhannisyan, Z. et al. The role of HLA-DQ8 β57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456, 534–538 (2008). This paper shows how lack of a negative charge at position β57 of an MHC class II molecule affects the TCR repertoire and amplifies the T cell response to gluten.
Vader, W. et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122, 1729–1737 (2002).
Vader, W. et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl Acad. Sci. USA 100, 12390–12395 (2003). This paper introduces the concept that there are thresholds for activation of gluten-specific T cells. According to this model, HLA-DQ expression and the available number of T cell-stimulatory gluten peptides are crucial limiting factors for coeliac disease development.
Ploski, R., Ek, J., Thorsby, E. & Sollid, L. M. On the HLA-DQ(α1*0501, β1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41, 173–177 (1993).
Karell, K. et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the european genetics cluster on celiac disease. Hum. Immunol. 64, 469–477 (2003).
Tollefsen, S. et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J. Clin. Invest. 116, 2226–2236 (2006).
Fallang, L. E. et al. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nature Immunol. 10, 1096–1101 (2009). This paper shows that HLA-DQ2.5 is better at presenting gluten peptides to T cells over a prolonged period than HLA-DQ2.2. The differential risk for coeliac disease of these two HLA molecules is likely to be related to this phenomenon.
Todd, J. A., Bell, J. I. & McDevitt, H. O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599–604 (1987).
Lee, K. H., Wucherpfennig, K. W. & Wiley, D. C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nature Immunol. 2, 501–507 (2001).
Henderson, K. N. et al. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity 27, 23–34 (2007).
Baker, F. J., Lee, M., Chien, Y. H. & Davis, M. M. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc. Natl Acad. Sci. USA 99, 9374–9379 (2002).
Kim, C. Y., Quarsten, H., Bergseng, E., Khosla, C. & Sollid, L. M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl Acad. Sci. USA 101, 4175–4179 (2004).
Qiao, S. W. et al. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J. Immunol. 175, 254–261 (2005).
Price, P. et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167, 257–274 (1999).
van de Wal, Y. et al. Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201, β1*0202) molecule. Immunogenetics 46, 484–492 (1997).
Henrickson, S. E. et al. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nature Immunol. 9, 282–291 (2008).
Tsuji, M. et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 323, 1488–1492 (2009).
Chen, Y. et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177–180 (1995).
Mora, J. R. & von Andrian, U. H. Retinoic acid: an educational “vitamin elixir” for gut-seeking T cells. Immunity 21, 458–460 (2004).
Iliev, I. D., Matteoli, G. & Rescigno, M. The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J. Exp. Med. 204, 2253–2257 (2007).
Faria, A. M. & Weiner, H. L. Oral tolerance. Immunol. Rev. 206, 232–259 (2005).
Husby, S., Mestecky, J., Moldoveanu, Z., Holland, S. & Elson, C. O. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152, 4663–4670 (1994).
Molberg, Ø. et al. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46, 103–109 (1997).
Jabri, B. et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118, 867–879 (2000).
Mention, J. J. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730–745 (2003).
Maiuri, L. et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119, 996–1006 (2000).
Waldmann, T. A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nature Rev. Immunol. 6, 595–601 (2006).
Blanco, P., Palucka, A. K., Pascual, V. & Banchereau, J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 19, 41–52 (2008).
Monteleone, G. et al. Role of interferon α in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48, 425–429 (2001).
Di Sabatino, A. et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 133, 1175–1187 (2007).
Ráki, M. et al. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131, 428–438 (2006).
Cammarota, G., Cuoco, L., Cianci, R., Pandolfi, F. & Gasbarrini, G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 356, 1494–1495 (2000).
Troncone, R. & Auricchio, S. Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. J. Pediatr. Gastroenterol. Nutr. 44, 527–528 (2007).
Benahmed, M. et al. Inhibition of TGF-β signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132, 994–1008 (2007).
Fina, D. et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57, 887–892 (2008).
Peluso, I. et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J. Immunol. 178, 732–739 (2007).
Perera, L. et al. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm. Bowel Dis. 13, 298–307 (2007).
Kasaian, M. T. et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16, 559–569 (2002).
Sollid, L. M., Molberg, Ø., McAdam, S. & Lundin, K. E. Autoantibodies in coeliac disease: tissue transglutaminase — guilt by association? Gut 41, 851–852 (1997).
Matysiak-Budnik, T. et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 205, 143–154 (2008).
Nimmerjahn, F. & Ravetch, J. V. Fcγ receptors as regulators of immune responses. Nature Rev. Immunol. 8, 34–47 (2008).
Patey-Mariaud de Serre, N. et al. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children. Bone Marrow Transplant 29, 223–230 (2002).
Cuenod, B. et al. Classification of intractable diarrhea in infancy using clinical and immunohistological criteria. Gastroenterology 99, 1037–1043 (1990).
Marsh, M. N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102, 330–354 (1992).
Kutlu, T. et al. Numbers of T cell receptor (TCR) αβ+ but not of TcR γδ+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 34, 208–214 (1993).
Black, K. E., Murray, J. A. & David, C. S. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169, 5595–5600 (2002).
de Kauwe, A. L. et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182, 7440–7450 (2009).
Yokoyama, S. et al. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc. Natl Acad. Sci. USA 106, 15849–15854 (2009).
Zhou, R., Wei, H., Sun, R., Zhang, J. & Tian, Z. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc. Natl Acad. Sci. USA 104, 7512–7515 (2007).
Louka, A. S. & Sollid, L. M. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 61, 105–117 (2003).
Roberts, A. I. et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167, 5527–5530 (2001).
Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357–366 (2004). The first paper to provide a molecular basis for IL-15-induced killer activity in vivo and antigen-nonspecific killing of IECs in coeliac disease and the first to report, together with reference 30, on the role of NKG2D in coeliac disease pathogenesis.
Jabri, B. et al. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 17, 487–499 (2002).
Meresse, B. et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203, 1343–1355 (2006). This paper shows genetic reprogramming of CTLs into NK cell-like cells and HLA-E induction in IECs in coeliac disease. It also provides a molecular basis for cytokine production and expansion of intraepithelial lymphocytes that do not recognize gluten peptides.
Tang, F. et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J. Exp. Med. 206, 707–719 (2009).
Werz, O. 5-lipoxygenase: cellular biology and molecular pharmacology. Curr. Drug Targets. Inflamm. Allergy 1, 23–44 (2002).
Halstensen, T. S., Scott, H. & Brandtzaeg, P. Intraepithelial T cells of the TcRγ/δ+ CD8− and Vδ1/Jδ1+ phenotypes are increased in coeliac disease. Scand. J. Immunol. 30, 665–672 (1989).
Wu, J., Groh, V. & Spies, T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γδ T cells. J. Immunol. 169, 1236–1240 (2002).
Spada, F. M. et al. Self-recognition of CD1 by γ/δ T cells: implications for innate immunity. J. Exp. Med. 191, 937–948 (2000).
Bhagat, G. et al. Small intestinal CD8+TCRγδ+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J. Clin. Invest. 118, 281–293 (2008).
Maki, M., Holm, K., Collin, P. & Savilahti, E. Increase in γ/δ T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease. Gut 32, 1412–1414 (1991).
Rosen, D. B. et al. A Structural basis for the association of DAP12 with mouse, but not human, NKG2D. J. Immunol. 173, 2470–2478 (2004).
Daum, S., Cellier, C. & Mulder, C. J. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19, 413–424 (2005).
Cellier, C. et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 114, 471–481 (1998). This paper identifies for the first time the phenotypic changes — that is, the loss of surface expression of the TCR — in intraepithelial lymphocytes of patients with refractory sprue.
Fehniger, T. A. et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med. 193, 219–231 (2001).
Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L. & Spies, T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 100, 9452–9457 (2003).
Ogasawara, K. et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20, 757–767 (2004).
Fabris, P. et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 340, 548 (1992).
Marazuela, M. et al. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy. Clin. Endocrinol. 44, 635–642 (1996).
Lundin, K. E. et al. Gliadin-specific, HLA-DQ(α1*0501, β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187–196 (1993).
Lundin, K. E., Scott, H., Fausa, O., Thorsby, E. & Sollid, L. M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum. Immunol. 41, 285–291 (1994).
Zhernakova, A., van Diemen, C. C. & Wijmenga, C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nature Rev. Genet. 10, 43–55 (2009).
Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med. 3, 797–801 (1997). This paper identifies TG2 as the dominant antigen recognized by autoantibodes of patients with coeliac disease.
Fritzler, M. & Wiik, A. Autoantibody Assays, Testing and Standardization (eds Rose, I. & Mackay, I.) (Elsevier Academic, Sydney, 2006).
Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273–281 (1998).
Ruckert, R. et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J. Immunol. 165, 2240–2250 (2000).
Lorand, L. & Graham, R. M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nature Rev. Mol. Cell Biol. 4, 140–156 (2003).
Molberg, Ø. et al. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur. J. Immunol. 31, 1317–1323 (2001).
Vader, L. W. et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 195, 643–649 (2002). This paper characterizes the enzyme specificity of TG2 and shows that the preferred substrate sequences are frequently found in proteins of wheat, rye and barley.
Dørum, S., Qiao, S. W., Sollid, L. M. & Fleckenstein, B. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J. Proteome Res. 8, 1748–1755 (2009).
Djilali-Saiah, I. et al. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43, 187–189 (1998).
Trynka, G. et al. Coeliac disease associated risk variants in TNFAIP3 and REL implicate altered NF-κB signalling. Gut 58, 1078–1083 (2009).
Acknowledgements
We thank patients with coeliac disease and their family members for their support of our research. We also thank the present and former members of our laboratories for their contributions to the work cited. Thanks are especially extended to V. Abadie for help with preparation of the figures. The work was supported by the US National Institutes of Health (grants RO1DK063158, RO1DK58727, P30DK42086), the Research Council of Norway, the European Commission FP7 programme, the South-Eastern Norway Regional Health Authority, the Juvenile Diabetes Research Foundation and the Norwegian Foundation for Health and Rehabilitation.
Author information
Authors and Affiliations
Corresponding author
Related links
Glossary
- Gluten
-
Wheat proteins that are not tolerated by people with coeliac disease. Similar proteins exist in barley and rye. Gluten consists of proline- and glutamine-rich gliadin and glutenin subcomponents.
- Villi
-
Projections into the lumen that have an outer layer that mainly consists of mature, absorptive enterocytes and also contain mucus-secreting goblet cells.
- Crypts
-
Tubular invaginations of the intestinal epithelium. At the base of the crypts there are paneth cells, which produce bactericidal defensins, and stem cells, which continuously divide and are the source of all intestinal epithelial cells.
- Regulatory T (TReg)cell
-
A specialized subpopulation of CD4+ T cells that can suppress the effector responses of other T cells. They are characterized by the expression of the transcription factor forkhead box P3 (FOXP3).
- Linkage disequilibrium
-
The nonrandom association of alleles at distinct loci owing to close physical proximity of the loci and a lack of recombination between them.
- T helper 1 cell
-
(TH1 cell). CD4+ T cells that produce interferon and tumour necrosis factor and support cell-mediated immunity.
- Mesenteric lymph nodes
-
Lymph nodes located at the base of the mesentery. They collect lymph (including cells and antigens) draining from the intestinal mucosa.
- Intraepithelial lymphocyte
-
(IEL). A T cell that resides in the basolateral side of the intestinal epithelium. IELs express either an αβ T cell receptor (TCR) or a γδ TCR.
- Interleukin-15
-
(IL-15). A pro-inflammatory cytokine that is trans-presented by the IL-15 receptor α-chain to neighbouring cells that express the IL-2 or IL-15 receptor β-chain and common γ-chain (γc). It is best known for its role in the development and/or survival of natural killer cells and memory CD8+ T cells. However, it is now recognized that IL-15 also enhances the effector functions of natural killer and cytotoxic T cells.
- Leader peptides
-
(Also known as signal sequences). Hydrophobic amino acid sequences that signal for proteins to translocate to the endoplasmic reticulum. The leader peptide is cleaved before a protein is transported from the cell.
- HLA-E
-
A human non-classical MHC class I molecule that is composed of the HLA-E heavy chain, β2-microglobulin, and a peptide that is often derived from the leader peptides of other MHC class I polypeptides or from certain microbial pathogens. HLA-E is recognized by CD94–NKG2 receptors.
- CD94–NKG2C
-
An activating C-type lectin natural killer cell receptor that is expressed by natural killer cells (under normal conditions) and some T cells (under pathological conditions).
- Polyinosinic–polycytidylic acid
-
(PolyI:C). A substance that is used as a mimic of viral double-stranded RNA.
- Non-obese diabetic (NOD) mice
-
A strain of mouse that spontaneously develops idiopathic autoimmune diabetes that closely resembles type 1 diabetes in humans and involves autoreactive T cell-mediated destruction of pancreatic β-islet cells. The main component of susceptibility is the MHC haplotype H2g7.
- Oral tolerance
-
Induction of peripheral immune tolerance by oral administration of antigen. Oral tolerance is now linked to the induction of forkhead box P3 (FOXP3)+ regulatory T cells.
- Lamina propria
-
The layer of mucosal tissue directly beneath the mucosal epithelial cell surface, in which effector cells for mucosal immunity reside.
- Plasmacytoid dendritic cell
-
(Plasmacytoid DC). An immature DC with a morphology that resembles that of a plasma cell. Plasmacytoid DCs produce large quantities of type I interferons (that is, interferon-α and interferon-β) after activation: for example, when stimulated through Toll-like receptors.
- Intraepithelial cytotoxic T lymphocytes
-
(Intraepithelial CTLs). Cytotoxic CD8+ T cells found in the epithelial layer that lines mucosal surfaces. Their main role is to maintain the integrity of the mucosa by eliminating infected epithelial cells.
- Immune complex
-
Complexes of antigen bound to antibody and, sometimes, components of the complement system. The levels of immune complexes are increased in many autoimmune disorders, in which they become deposited in tissues and cause tissue damage.
- NKG2D
-
(Natural killer group 2, member D). A co-activating C-type lectin natural killer cell receptor that is expressed by human cytotoxic T cells, innate-like T cells and NK cells.
Rights and permissions
About this article
Cite this article
Jabri, B., Sollid, L. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 9, 858–870 (2009). https://doi.org/10.1038/nri2670
Issue Date:
DOI: https://doi.org/10.1038/nri2670
This article is cited by
-
Novel Bacteroides Vulgatus strain protects against gluten-induced break of human celiac gut epithelial homeostasis: a pre-clinical proof-of-concept study
Pediatric Research (2024)
-
Role of age in dynamics of autoantibodies in pediatric Celiac disease
Italian Journal of Pediatrics (2023)
-
Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders
European Journal of Pediatrics (2023)
-
Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis
Nature Medicine (2023)